Professor Rachelle Buchbinder AO awarded the Royal Society of Victoria Medal for Excellence – Monash University

Share Article

If you’re feeling unwell, get tested for COVID-19 and stay home until you’ve received a negative result. View our latest COVID-19 updates.
You are here:

The Council of the Royal Society of Victoria (RSV) has selected Professor Rachelle Buchbinder AO to receive the 2022 Medal for Excellence in Scientific Research, in recognition of her outstanding leadership in Biomedical and Health Sciences research.
Dean of Medicine, Nursing and Health Sciences, Professor Christina Mitchell congratulated Professor Buchbinder. “This medal recognises an outstanding contribution to evidence-based healthcare and the reduction of wasteful practices in medicine. We are very proud of Professor Buchbinder”
The medal will be presented at a ceremony in December.  

Read more on the RSV website.
More on Professor Buchbinder’s career:
A career dedicated to optimising health for people with musculoskeletal conditions
Poor care and unnecessary research contribute to the health system and community burden of musculoskeletal conditions, a major concern for Rachelle Buchbinder, an Australian NHMRC Leadership 3 Investigator Fellow. She has been the Director of the Monash-Cabrini Department of Musculoskeletal Health and Clinical Epidemiology since its inception in 2001, and a Professor in the Monash University Department of Epidemiology and Preventive Medicine since 2007. She is a rheumatologist and clinical epidemiologist who combines clinical practice with research in a wide range of multidisciplinary projects relating to arthritis and musculoskeletal conditions.

Other roles include Coordinating Editor of Cochrane Musculoskeletal, Back and Neck; founding member and Chair, Executive Committee, NHMRC Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Centre of Research Excellence; and Member of the Executive for Wiser Healthcare, a national collaboration tackling the problem of overdiagnosis and overtreatment. In 2020 she was awarded an Officer of the Order of Australia (AO) for services to epidemiology and rheumatology.
Health outcomes, impact and future research
Professor Buchbinder chaired the steering group for The Lancet Low Back Pain Series, a series of three papers published in March 2018.  It was a call to action by 31 of the world’s leading back pain researchers from 12 countries, warning that low back pain is being mistreated on an enormous scale. The series drew attention to the urgent need for action to reduce the current and projected disease burden from low back pain. In particular, it outlined the epidemic of low-value care for low back pain across the world and identified promising solutions.
Professor Buchbinder’s current broad program of work, funded through various NHMRC schemes including her fellowship, a program grant, partnership centre, 4 CREs and project grants include;
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.
For more news, visit Medicine, Nursing and Health Sciences or Monash University.
MEDIA ENQUIRIES
E: [email protected]
We acknowledge and pay respects to the Elders and Traditional Owners of the land on which our Australian campuses stand. Information for Indigenous Australians
ABN 12 377 614 012
Monash University: 00008C
Monash College: 01857J
Chief Marketing Officer
University Marketing, Admissions and Communications
Medicine, Nursing and Health Sciences Webmaster Team
Last updated: Oct 2022

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness